Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron Patch vs Palonosetron for Delayed CINV in Breast Cancer
NCT04912271Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of granisetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Fudan University. Status: unknown.
02
Drugs
granisetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04912271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04912271.